Literature DB >> 19241094

Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells.

Frédéric Schmitt1, Mathieu Auzias, Petr Stepnicka, Yoshihisa Sei, Kentaro Yamaguchi, Georg Süss-Fink, Bruno Therrien, Lucienne Juillerat-Jeanneret.   

Abstract

Diruthenium tetracarbonyl complexes of the type [Ru2(CO)4(l2-g2-O2CR)2L2] containing a Ru-Ru backbone with four equatorial carbonyl ligands, two carboxylato bridges, and two axial two-electron ligands in a sawhorse-like geometry have been synthesized with porphyrin-derived substituents in the axial ligands [1: R is CH3, L is 5-(4-pyridyl)-10,15,20-triphenyl-21,23H-porphyrin], in the bridging carboxylato ligands [2: RCO2H is 5-(4-carboxyphenyl)-10,15,20-triphenyl-21,23H-porphyrin, L is PPh3; 3: RCO2H is 5-(4-carboxyphenyl)-10,15,20-triphenyl-21,23H-porphyrin, L is 1,3,5-triaza-7-phosphatricyclo [3.3.1.1]decane], or in both positions [4: RCO2H is 5-(4-carboxyphenyl)-10,15,20-triphenyl-21,23H-porphyrin, L is 5-(4-pyridyl)-10,15,20-triphenyl-21,23H-porphyrin]. Compounds 1-3 were assessed on different types of human cancer cells and normal cells. Their uptake by cells was quantified by fluorescence and checked by fluorescence microscopy. These compounds were taken up by human HeLa cervix and A2780 and Ovcar ovarian carcinoma cells but not by normal cells and other cancer cell lines (A549 pulmonary, Me300 melanoma, PC3 and LnCap prostate, KB head and neck, MDAMB231 and MCF7 breast, or HT29 colon cancer cells). The compounds demonstrated no cytotoxicity in the absence of laser irradiation but exhibited good phototoxicities in HeLa and A2780 cells when exposed to laser light at 652 nm, displaying an LD50 between 1.5 and 6.5 J/cm2 in these two cell lines and more than 15 J/cm2 for the others. Thus, these types of porphyric compound present specificity for cancer cell lines of the female reproductive system and not for normal cells; thus being promising new organometallic photosensitizers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241094     DOI: 10.1007/s00775-009-0482-z

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  24 in total

1.  Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(II) conjugates.

Authors:  Christian Lottner; Ruth Knuechel; Guenther Bernhardt; Henri Brunner
Journal:  Cancer Lett       Date:  2004-01-20       Impact factor: 8.679

2.  INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

Authors:  B ROSENBERG; L VANCAMP; T KRIGAS
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

3.  Perpendicularly Arranged Ruthenium Porphyrin Dimers and Trimers.

Authors:  Kenji Funatsu; Akira Kimura; Taira Imamura; Akio Ichimura; Yoichi Sasaki
Journal:  Inorg Chem       Date:  1997-04-09       Impact factor: 5.165

4.  Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents.

Authors:  Christian Lottner; Karl-Christian Bart; Günther Bernhardt; Henri Brunner
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

5.  Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.

Authors:  Raphaël Schneider; Frédéric Schmitt; Céline Frochot; Yves Fort; Natacha Lourette; François Guillemin; Jean-François Müller; Muriel Barberi-Heyob
Journal:  Bioorg Med Chem       Date:  2005-04-15       Impact factor: 3.641

6.  The effect of tissue and cellular pH on the selective biodistribution of porphyrin-type photochemotherapeutic agents: a volumetric titration study.

Authors:  A J Barrett; J C Kennedy; R A Jones; P Nadeau; R H Pottier
Journal:  J Photochem Photobiol B       Date:  1990-07       Impact factor: 6.252

Review 7.  Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.

Authors:  Anne Vessières; Siden Top; Wolfgang Beck; Elizabeth Hillard; Gérard Jaouen
Journal:  Dalton Trans       Date:  2005-09-27       Impact factor: 4.390

8.  Glycoside esters of 5-aminolevulinic acid for photodynamic therapy of cancer.

Authors:  Ramakrishnan Vallinayagam; Frédéric Schmitt; Jérome Barge; Georges Wagnieres; Virginie Wenger; Reinhard Neier; Lucienne Juillerat-Jeanneret
Journal:  Bioconjug Chem       Date:  2008-03-15       Impact factor: 4.774

Review 9.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

10.  Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.

Authors:  Carsten A Vock; Wee Han Ang; Claudine Scolaro; Andrew D Phillips; Lucienne Lagopoulos; Lucienne Juillerat-Jeanneret; Gianni Sava; Rosario Scopelliti; Paul J Dyson
Journal:  J Med Chem       Date:  2007-04-10       Impact factor: 7.446

View more
  3 in total

1.  Hydrophilic CO-Releasing Material of PEGlyated Ruthenium Carbonyl Complex.

Authors:  Xiao Zhang; Nan Guo; Shuhong Yang; Huma Khan; Weiqiang Zhang
Journal:  Materials (Basel)       Date:  2022-05-18       Impact factor: 3.748

Review 2.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

Review 3.  Chemical approaches for the enhancement of porphyrin skeleton-based photodynamic therapy.

Authors:  Yuyan Lin; Tao Zhou; Renren Bai; Yuanyuan Xie
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.